Association of alveolar rhabdomyosarcoma with the Beckwith-Wiedemann syndrome

Pediatric and Developmental Pathology

Volumn 4, Issue 6, 2001, Pages 550-558

  Smith, Adam C ^a,b   Squire, Jeremy A ^c,d   Thorner, Paul ^a,e   Zielenska, Maria ^a,e   Shuman, Cheryl ^c,e   Grant, Ronald ^e   Chitayat, David ^c,e   Nishikawa, Joy L ^c,e   Weksberg, Rosanna ^a,b,c,e  

^a UNIVERSITY OF TORONTO   (Canada)

^b HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d PRINCESS MARGARET HOSPITAL   (Canada)

^e HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

11p15; Alveolar rhabdomyosarcoma; Beckwith Wiedemann syndrome; Cancer

Indexed keywords

ARTICLE; BECKWITH WIEDEMANN SYNDROME; CASE REPORT; CHILD; CHROMOSOME 11P; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION; DISEASE ASSOCIATION; EMBRYONAL RHABDOMYOSARCOMA; FEMALE; HEPATOBLASTOMA; HUMAN; INFANT; MACROGLOSSIA; MACROSOMIA; MALE; NEPHROBLASTOMA; NEUROBLASTOMA; PRIORITY JOURNAL; RHABDOMYOSARCOMA; UMBILICAL HERNIA;

ADOLESCENT; BECKWITH-WIEDEMANN SYNDROME; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 11; DNA, NEOPLASM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT, NEWBORN; MALE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHABDOMYOSARCOMA, ALVEOLAR; SOFT TISSUE NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0035166378     PISSN: 10935266     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10024001-0110-6     Document Type: Article

References (42)

1. Beckwith-Wiedemann syndrome: Imprinting in clusters revisited
2. The impact of genomic imprinting for neurobehavioral and developmental disorders
3. Loss of imprinting of a paternally expressed transcript, with antisense orientation to KVLQT1, occurs frequently in Beckwith-Wiedemann syndrome and is independent of insulin-like growth factor II imprinting
4. A maternally methylated CpG island in KvLQT1 is associated with an antisense paternal transcript and loss of imprinting in Beckwith-Wiedemann syndrome
5. Epigenotype-phenotype correlations in Beckwith-Wiedemann syndrome
6. Imprinting status of 11p15 genes in Beckwith-Wiedemann syndrome patients with CDKN1C mutations
7. General principles of the epidemiology of childhood cancer
8. Tumours and hemihypertrophy associated with Wiedemann-Beckwith syndrome
9. Increased tumor risk for BWS patients correlates with aberrant H19 and not KCNQ1OT1 methylation: Occurrence of KCNQ1OT1 hypomethylation in familial cases of BWS
10. Activation of an imprinted allele of the insulin-like growth factor II gene implicated in rhabdomyosarcoma
11. Neoplasms associated with the Beckwith-Wiedemann syndrome
12. Molecular analysis of a patient with Beckwith-Wiedemann syndrome, rhabdomyosarcoma and renal cell carcinoma
13. Favorable outcome in children with Beckwith-Wiedemann syndrome and intraabdominal malignant tumors
14. Case report: Urinary bladder rhabdomyosarcoma associated with Beckwith-Wiedemann syndrome
15. Loss of heterozygosity in three embryonal tumours suggests a common pathogenetic mechanism
16. A model for embryonal rhabdomyosarcoma tumorigenesis that involves genome imprinting
17. Molecular differential pathology of rhabdomyosarcoma
18. Genomic imprinting and Wilms' tumor
19. Role of genomic imprinting in Wilms' tumour and overgrowth disorders
20. Loss of imprinting in hepatoblastoma
21. Disruption of imprinted genes at chromosome region 11p15.5 in paediatric rhabdomyosarcoma
22. A constitutional BWS-related t(11;16) chromosome translocation occurring in the same region of chromosome 16 implicated in Wilms' tumors
23. High incidence of loss of heterozygosity and abnormal imprinting of H19 and IGF2 genes in invasive cervical carcinomas. Uncoupling of H19 and IGF2 expression and biallelic hypomethylation of H19
24. Rhabdomyosarcoma and other soft tissue sarcomas of childhood
25. Classification of rhabdomyosarcomas and related sarcomas. Pathologic aspects and proposal for a new classification - An intergroup rhabdomyosarcoma study
26. Intergroup Rhabdomyosarcoma Study: Update for pathologists
27. Application of comparative genomic hybridization, spectral karyotyping, and microarray analysis in the identification of subtype-specific patterns of genomic changes in rhabdomyosarcoma
28. In vivo amplification of the PAX3-FKHR and PAX7-FKHR fusion genes in alveolar rhabdomyosarcoma
29. Molecular assays for chromosomal translocations in the diagnosis of pediatric soft tissue sarcomas
30. Familial Wiedemann-Beckwith syndrome and a second Wilms tumor locus both map to 11p15.5
31. Genetic linkage of Beckwith-Wiedemann syndrome to 11p15
32. Molecular characterization of Beckwith-Wiedemann syndrome (BWS) patients with partial duplication of chromosome 11p excludes the gene MYOD1 from the BWS region
33. Molecular characterization of cytogenetic alterations associated with the Beckwith-Wiedemann syndrome (BWS) phenotype refines the localization and suggests the gene for BWS is imprinted
34. Parental imprinting of human chromosome region 11p15.3-pter involved in the Beckwith-Wiedemann syndrome and various human neoplasia
35. CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/IGF2 locus
36. Molecular genetics of Beckwith-Wiedemann syndrome
37. Chromosomal localization of the human rhabdomyosarcoma locus by mitotic recombination mapping
38. Mono- and bi-allelic expression of insulin-like growth factor II gene in human muscle tumors
39. cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene
40. The role of chimeric paired box transcription factors in the pathogenesis of pediatric rhabdomysarcoma
41. Transcriptional map of 170-kb region at chromosome 11p15.5: Identification and mutational analysis of the BWR1A gene reveals the presence of mutations in tumor samples